Leukotriene D₄ enhances the function of endothelin-1-primed fibroblasts

Airway inflammation is accompanied by structural changes, termed remodeling, that lead to lung dysfunction over the long term. Although both endothelin-1 (ET-1) and cysteinyl leukotrienes (CysLTs) appear to be involved in airway remodeling in several lung diseases, how these molecules interact remains largely unknown. In this study, we examined the effects of leukotriene (LT) D₄ on the function of ET-1-primed fibroblasts. ET-1 at 10^{- 7} M up-regulated the expression of the CysLT receptors at both the mRNA and protein levels in human lung fibroblasts. LTD₄ enhanced matrix metalloproteinase-2 and pro-collagen production, and α-smooth muscle actin expression of ET-1-primed fibroblasts, but had little or no effect on unprimed fibroblasts. The CysLT1 receptor antagonist montelukast completely abrogated the effects of LTD₄. Our data suggested that LTD₄ may act as a precipitating factor during ET-1-mediated airway remodeling and that CysLT1 receptor antagonists may have a role in preventing aberrant extracellular matrix degradation.